August 4, 2020 by Chain Drug Review
Amazon/PillPack, Horizon, Prime Therapeutics
Leading Headlines, Pharmacy

EAGAN, Minn. — To make it easier for members to fill and manage multiple prescriptions, Horizon Healthcare Services, Inc. (Horizon), New Jersey’s oldest and largest health insurer, and its pharmacy benefit manager Prime Therapeutics, now offer its members an integrated pharmacy experience with PillPack by Amazon Pharmacy. Horizon now provides simplified PillPack sign up, choice of
January 30, 2018 by Chain Drug Review
Aetna, AllianceRx Walgreens Prime, Amazon, Berkshire Hathaway, Brian Tanquilut, CVS Health, employee health care, employee health care partnership, EnvisionRxOptions, Health Dialog, Health Transformation Alliance, HTA, Jaimie Dimon, Jeff Bezo, JPMorgan Chase, Prime Therapeutics, Rite Aid, Walgreens Boots Alliance, Warren Buffet
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

NEW YORK — Three of the largest U.S. companies — Berkshire Hathaway, Amazon and JPMorgan Chase & Co. — have joined together to take employee health care into their own hands. Berkshire Hathaway, Amazon and JPMorgan Chase said Tuesday that they plan to form an independent health care company to provide their employees accessible, affordable and quality care.
December 8, 2017 by Chain Drug Review
Jonathan Gavras, liraglutide, Novo Nordisk, Ozempic, Prime Therapeutics, semaglutide, Todd Hobbs, type 2 diabetes medication, Victoza
Pharmacy, Supplier News

PLAINSBORO, N.J. — Novo Nordisk this week gained Food and Drug Administration approval for Ozempic (semaglutide injection), a medication for type 2 diabetes. Also this week, Novo Nordisk and pharmacy benefit manager Prime Therapeutics said they signed a value-based contract for Victoza (liraglutide injection), another type 2 diabetes medication. A glucagon-like peptide (GLP-1) receptor agonist,
November 3, 2017 by CDR Blog and Chain Drug Review
Bad for Your Health: Lawsuit Advertising Implications and Solutions, ILR, Jonathan Gavras, Lawsuit ads targeting prescription drugs, Lisa Rickard, opioid crisis, opioid painkillers, Prime Therapeutics, safe disposal of controlled substances, U.S. Chamber Institute for Legal Reform, Xarelto
CDR Blog

Some recently released research uncovered a couple of disconcerting trends concerning prescription drugs. Lawsuit ads targeting prescription drugs and medical devices have caused at least 61 serious medical events, including six deaths, according to a report from the U.S. Chamber Institute for Legal Reform (ILR). This marks an increase from previous reports, ILR said. Titled
October 23, 2017 by Geoff Walden and Chain Drug Review
Accredo Health Group, AllianceRx Walgreens Prime, CVS Caremark, Express Scripts, Joel Wright, Prime Therapeutics, Walgreens
2017, Issue 10-23-2017, Issues, News

ORLANDO, Fla. — Merging the specialty pharmacy and mail service capabilities of Walgreens and Prime Therapeutics LLC has created a whole that is greater than the sum of its parts, says Joel Wright, chief executive officer of the newly formed AllianceRx Walgreens Prime. Increased purchasing scale and the addition of Prime’s clinical and lives management
October 23, 2017 by Mark Baumgartner and Chain Drug Review
Alex Gourlay, AmerisourceBergen, Blue Cross Blue Shield Association, Jonathan Gavras, Kim Holland, Pfizer, Prime Therapeutics, Walgreens, Walgreens medication disposal kiosks
2017, Issue 10-23-2017, Issues, News
DEERFIELD, Ill. — Four prominent players in the health care sector are coming together to help combat opioid abuse by increasing the availability of Walgreens medication disposal kiosks. The goal is to collect 300 tons of unwanted medications over the next two years through kiosks at about 1,500 Walgreens stores nationwide. Walgreens now has about
October 4, 2017 by Chain Drug Review
Alex Gourlay, AmerisourceBergen, Blue Cross Blue Shield Association, Bob Mauch, Freda Lewis-Hall, Jonathan Gavras, Kim Holland, opioid abuse, opioid epidemic, Pfizer, Prime Therapeutics, Walgreens, Walgreens medication disposal kiosks
Pharmacy, Retail News

DEERFIELD, Ill. — AmerisourceBergen, the Blue Cross Blue Shield Association, Pfizer and Prime Therapeutics are helping Walgreens fight the national opioid epidemic by expanding the availability of safe medication disposal kiosks. The drug chain said Wednesday that the effort will bring the medication disposal units to an additional 900 Walgreens stores near military bases and
October 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Joel Wright, Prime Therapeutics, specialty pharmacy, Walgreens
Featured Articles, Leading Headlines, Pharmacy, Retail News

ORLANDO, Fla. — Walgreens and Prime Therapeutics LLC have inaugurated AllianceRx Walgreens Prime, the brand for the joint central specialty pharmacy and mail services company they formed earlier this year. The companies said the AllianceRx Walgreens Prime launch included the unveiling of new signage at its headquarters in Orlando, Fla., and at other company-owned facilities
April 22, 2017 by Greg Jacobson and Chain Drug Review
Alex Katen, AllianceRx Walgreens Prime, Daniel Tardiff, Don Vidic, Guillermo Sollberger, Jim Adams, Jim DuCharme, Joel Wright, Prime Therapeutics, Walgreens, Walgreens Boots Alliance
2017, Issue 04-24-2017, Issues, News
DEERFIELD, Ill. — Walgreens Boots Alliance Inc. (WBA) and Prime Therapeutics LLC have completed the formation of a combined central specialty pharmacy and mail service company, a move that was first announced last August. The leadership team of the new enterprise, AllianceRx Walgreens Prime, has also been revealed. Joel Wright, formerly divisional vice president for
April 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Blue Cross and Blue Shield Federal Employee Program, CVS Health, Prime Therapeutics, Walgreens
Business, Pharmacy, Retail News

NEW YORK — Next year, the specialty pharmacy services contract for the Blue Cross and Blue Shield Federal Employee Program (FEP) is slated to pass from CVS Health to Prime Therapeutics LLC. CVS said its specialty pharmacy contract with BCBS FEP will terminate at the end of 2017. Under separate agreements that run through 2018,
April 3, 2017 by Chain Drug Review
AllianceRx Walgreens Prime, Jim DuCharme, Joel Wright, Prime Therapeutics, Walgreens
Business, Featured Articles, Leading Headlines, Pharmacy, Retail News

DEERFIELD, Ill., and ST. PAUL, Minn. — Walgreens and pharmacy benefit manager Prime Therapeutics LLC have completed their transaction to form a joint pharmacy services company and announced its leadership. Called AllianceRx Walgreens Prime and based in Orlando, Fla., the new company melds the central specialty pharmacy and mail service businesses of Walgreens and Prime
December 12, 2016 by Geoff Walden and Chain Drug Review
Alex Gourlay, community pharmacy, pharmacy industry, Prime Therapeutics, Walgreens, Walgreens Boots Alliance
Featured Articles, Issue 12-12-2016, Issues, Leading Headlines, News, Pharmacy, Retail News

DEERFIELD, Ill. — In a country where health care is rife with wasted time and money, Walgreens is committed to making pharmacy more efficient. One measure of the practice’s current inefficiency, says Alex Gourlay, co-chief operating officer of Walgreens Boots Alliance Inc., is the large number of prescriptions that need additional authorization on the way
November 11, 2016 by CDR Blog and Chain Drug Review
Adam Fein, CVS Caremark, CVS Health, CVS Pharmacy, Drug Channels, Drug Channels Institute, Maintenance Choice, OptumRx, Pembroke Consulting, pharmacy industry, Prime Therapeutics, Tricare, Walgreens Boots Alliance, WBA
CDR Blog

CVS Health’s scaled-back 2017 guidance, given in its third-quarter report this week, spotlights an intensifying competitive battle with rival Walgreens Boots Alliance. CVS reported that for fiscal 2017 it expects to lose over 40 million retail prescriptions due to marketplace changes, notably narrower retail pharmacy networks excluding CVS Pharmacy drug stores. The announcement sent CVS
October 20, 2016 by Chain Drug Review
AmerisourceBergen, Express Scripts, Prime Therapeutics, Rite Aid, Stefano Pessina, Walgreens, Walgreens Boots Alliance, WBA
Business, Leading Headlines, Retail News

DEERFIELD, Ill. — As talks roll on to gain regulatory clearance for its acquisition of Rite Aid Corp., Walgreens Boots Alliance (WBA) posted adjusted earnings for its fiscal 2016 fourth quarter and full year that beat Wall Street’s estimates. WBA said Thursday that GAAP net earnings attributable to Walgreens Boots Alliance totaled $1.03 billion, or